The relationship between visceral adiposity and the risk of erosive esophagitis in severely obese Chinese patients

Obesity

Volumn 18, Issue 11, 2010, Pages 2165-2169

  Tai, Chi Ming ^a,b   Lee, Yi Chia ^c,d   Tu, Hung Pin ^b   Huang, Chih Kun ^a   Wu, Ming Tin ^e,f   Chang, Chi Yang ^a   Lee, Ching Tai ^a   Wu, Ming Shiang ^c   Lin, Jaw Town ^a,c   Wang, Wen Ming ^b,g,h  

^a I SHOU UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BARIATRIC SURGERY; CHINA; CROSS-SECTIONAL STUDY; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INCIDENCE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; MORBID OBESITY; OBESITY; PATHOLOGY; PREVALENCE; REFLUX ESOPHAGITIS; RISK; RISK FACTOR; STATISTICAL MODEL; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; ANALYSIS OF VARIANCE; BARIATRIC SURGERY; CHINA; CROSS-SECTIONAL STUDIES; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INCIDENCE; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LOGISTIC MODELS; MALE; OBESITY, ABDOMINAL; OBESITY, MORBID; ODDS RATIO; PREVALENCE; RISK FACTORS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 78049238558     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.143     Document Type: Article

References (31)

1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54: 710-717.
2. Goh KL. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol 2004;19 Suppl 3:S22-S25.
3. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006;4:398-407.
4. Chung SJ, Kim D, Park MJ et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008;57: 1360-1365.
5. Lee HL, Eun CS, Lee OY et al. Association between erosive esophagitis and visceral fat accumulation quantified by abdominal CT scan. J Clin Gastroenterol 2009;43:240-243.
6. Pandolfino JE, Kwiatek MA, Kahrilas PJ. The pathophysiologic basis for epidemiologic trends in gastroesophageal reflux disease. Gastroenterol Clin North Am 2008;37:827-43, viii.
7. El-Serag H. Role of obesity in GORD-related disorders. Gut 2008;57: 281-284.
8. Pandolfino JE, El-Serag HB, Zhang Q et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 2006;130: 639-649.
9. Park JH, Park DI, Kim HJ et al. Metabolic syndrome is associated with erosive esophagitis. World J Gastroenterol 2008;14:5442-5447.
10. Moki F, Kusano M, Mizuide M et al. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther 2007;26:1069-1075.
11. Lee YC, Yen AM, Tai JJ et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut 2009;58: 174-181.
12. Iwasaki E, Suzuki H, Sugino Y et al. Decreased levels of adiponectin in obese patients with gastroesophageal reflux evaluated by videoesophagography: possible relationship between gastroesophageal reflux and metabolic syndrome. J Gastroenterol Hepatol 2008;23 Suppl 2:S216-S221.
13. Ortiz V, Ponce M, Fernández A et al. Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients. Obesity (Silver Spring) 2006;14:696-700.
14. Suter M, Dorta G, Giusti V, Calmes JM. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg 2004;14:959-966.
15. Tai CM, Lee YC, Wu MS et al. The effect of Roux-en-Y gastric bypass on gastroesophageal reflux disease in morbidly obese Chinese patients. Obes Surg 2009;19:565-570.
16. Alberti KG, Eckel RH, Grundy SM et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
17. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495.
18. Lee YC, Wang H P, Chiu HM et al. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol 2006;21:798-804.
19. Farup C, Kleinman L, Sloan S et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001;161:45-52.
20. Johnson DA, Younes Z, Hogan WJ. Endoscopic assessment of hiatal hernia repair. Gastrointest Endosc 2000;52:650-659.
21. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol 2006;101:2619-2628. (Pubitemid 44665262)
22. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199-211.
23. Lagergren J, Bergström R, Nyrén O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut 2000;47:26-29.
24. Kang MS, Park DI, Oh SY et al. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population. J Gastroenterol Hepatol 2007;22:1656-1661.
25. Jeppesen J, Hansen TW, Rasmussen S et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 2007;49:2112-2119.
26. Cnop M, Landchild MJ, Vidal J et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002;51: 1005-1015.
27. Pontiroli AE, Pizzocri P, Giacomelli M et al. Ultrasound measurement of visceral and subcutaneous fat in morbidly obese patients before and after laparoscopic adjustable gastric banding: comparison with computerized tomography and with anthropometric measurements. Obes Surg 2002;12:648-651.
28. Pouliot MC, Després J P, Lemieux S et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-468.
29. Westphal SA. Obesity, abdominal obesity, and insulin resistance. Clin Cornerstone 2008;9:23-29; discussion 30.
30. Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 2004;126:660-664.
31. Kuzuya M, Ando F, Iguchi A, Shimokata H. Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort. Atherosclerosis 2007;191:305-312.